Search company, investor...

Predict your next investment

NB Capital company logo
Asset/Investment Management
nb.capital

Investments

21

Portfolio Exits

2

Funds

4

About NB Capital

NB CAPITAL is a privately-owned investment firm specialized in identifying, investing and supporting start-ups in the scaling stage. NB CAPITAL focuses in FinTech, logistics / transportation, CleanTech, cross border commerce and EdTech industries, in LATAM and particularly Brazil.

Headquarters Location

Maxime Office Tower - Sala 1309 Avenida 9 de Julho n. 3575

Jundiai, 13208-056,

Brazil

+55 11 99710.4077

Are you an investor?
Submit your portfolio details now to be considered in our investor rankings.

Latest NB Capital News

Play2sell recebe investimento da Latin America Angels Society

Mar 29, 2018

Além da LAAS, investidores-anjo da ABMI e os fundos de investimento JUPTER AdVentures e o NB Capital também participaram da rodada Play2sell, startup de construtech, recebeu investimento da Latin America Angels Society (LAAS). Valor do aporte não foi revelado por ambas as partes. Além da LAAS, investidores-anjo da Associação Brasileira do Mercado Imobiliário (ABMI) e os fundos de investimento JUPTER AdVentures e o NB Capital também participaram da rodada. O capital investido na startup já possui destino. A companhia irá utilizar para aprimorar o produto, aquisição de clientes e em marketing. Segundo o CEO da Play2Sell, Felipe dos Santos, depois de conquistar este setor da construtech, o plano é investir em outras verticais como varejo, automotivo e vendas diretas. Fundada em 2017, a startup usa técnicas de gamificação para capacitar corretores e fazer a gestão das vendas por meio de um app. “Percebemos que existe uma dor muito grande do mercado com relação à qualificação dos times de vendas, em especial no setor imobiliário. Mas os treinamentos tradicionais não são escaláveis, acessíveis e não engajam. Em geral, os profissionais de vendas acham que estão perdendo tempo. Por isso, nossa solução transmite esse conhecimento de uma maneira divertida e que pode ser ‘jogada’ a qualquer hora, em qualquer lugar’”, explica Felipe dos Santos. A Play2Sell também participou da edição paulista do programa do Founder Institute (FI), aceleradora global que tem base no Vale do Silício, nos Estados Unidos, e possui atividades em algumas cidades brasileiras. Segundo o diretor executivo do Founder Institute Brazil e co-fundador do JUPTER, Nima Kazerooni, a Play2Sell foi uma das startups que saiu mais preparada para captar investimento depois da graduação. Preparação esta que rendeu o atual investimento, apenas 5 meses após a criação da startup. O CEO da Play2Sell ainda garante que este será um ano de muito crescimento para a empresa. Elena Costa

NB Capital Investments

21 Investments

NB Capital has made 21 investments. Their latest investment was in Play2Sell as part of their Seed VC on March 3, 2018.

CBI Logo

NB Capital Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

3/28/2018

Seed VC

Play2Sell

Yes

JUPTER, Latin America Angels Society, and Undisclosed Angel Investors

2

2/11/2008

Series C

Rose Pharma

$6M

No

123 Investment Managers, Capnova, and Undisclosed Investors

1

1/3/2008

Series A

Blue Note Pharmaceuticals

Yes

1

4/11/2007

Series A

Subscribe to see more

Subscribe to see more

10

10/19/2006

Series B

Subscribe to see more

$99M

Subscribe to see more

10

Date

3/28/2018

2/11/2008

1/3/2008

4/11/2007

10/19/2006

Round

Seed VC

Series C

Series A

Series A

Series B

Company

Play2Sell

Rose Pharma

Blue Note Pharmaceuticals

Subscribe to see more

Subscribe to see more

Amount

$6M

$99M

New?

Yes

No

Yes

Subscribe to see more

Subscribe to see more

Co-Investors

JUPTER, Latin America Angels Society, and Undisclosed Angel Investors

123 Investment Managers, Capnova, and Undisclosed Investors

Sources

2

1

1

10

10

NB Capital Portfolio Exits

2 Portfolio Exits

NB Capital has 2 portfolio exits. Their latest portfolio exit was Curalogic on June 01, 2006.

Date

Exit

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Acquirer

Sources

6/1/2006

IPO

$99M

Public

4/28/2005

Acquired

Subscribe to see more

$99M

Subscribe to see more

0

Date

6/1/2006

4/28/2005

Exit

IPO

Acquired

Companies

Subscribe to see more

Valuation

$99M

$99M

Acquirer

Public

Subscribe to see more

Sources

0

NB Capital Fund History

4 Fund Histories

NB Capital has 4 funds, including Nordic Biotech Opportunity Fund K/S.

Closing Date

Fund

Fund Type

Status

Amount

Sources

12/31/2008

Nordic Biotech Opportunity Fund K/S

Early-Stage Venture Capital

Closed

$17.63M

1

12/31/2008

NB PI

Subscribe to see more

Subscribe to see more

$99M

10

7/31/2002

Nordic Biotech K/S

Subscribe to see more

Subscribe to see more

$99M

10

Nordic Biotech Venture Fund II K/S

Subscribe to see more

Subscribe to see more

10

Closing Date

12/31/2008

12/31/2008

7/31/2002

Fund

Nordic Biotech Opportunity Fund K/S

NB PI

Nordic Biotech K/S

Nordic Biotech Venture Fund II K/S

Fund Type

Early-Stage Venture Capital

Subscribe to see more

Subscribe to see more

Subscribe to see more

Status

Closed

Subscribe to see more

Subscribe to see more

Subscribe to see more

Amount

$17.63M

$99M

$99M

Sources

1

10

10

10

NB Capital Team

4 Team Members

NB Capital has 4 team members, including current Founder, Owner, Christian Karsten Hansen.

Name

Work History

Title

Status

Christian Karsten Hansen

Founder, Owner

Current

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Name

Christian Karsten Hansen

Subscribe to see more

Subscribe to see more

Subscribe to see more

Work History

Title

Founder, Owner

Subscribe to see more

Subscribe to see more

Subscribe to see more

Status

Current

Subscribe to see more

Subscribe to see more

Subscribe to see more

Loading...

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.